Previous studies found that mutations in LIAS were associated with non-ketotic hyperglycinaemia-like early-onset convulsions and encephalopathy combined with a defect in mitochondrial energy metabolism, and LIAS overexpression inhibited oxidative stress and inflammation (38–40). Here, LIAS is linked to Encephalopathy.